NBIXNEUROCRINE BIOSCIENCES INC
CUSIP 64125C109 · common stock
7 tracked investors held NEUROCRINE BIOSCIENCES INC (NBIX) at the end of Q3 2026, worth $921.3M in total. The largest holder was Dodge & Cox, with 0.4% of its portfolio. 2 investors opened new positions this quarter, including Lee Ainslie.
Holders · Q3 2026
7
New holders
2
Value held
$921.3M
Quarter-end price (est.)
$141.84
Investors holding NBIX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 0.42% | 5,504,578 | $780.8M | REDUCE-1.4% |
| PRIMECAP Management PRIMECAP Management Co | 0.04% | 505,332 | $71.7M | ADD+2.8% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.09% | 315,877 | $44.8M | REDUCE-15.0% |
| Jeremy Grantham Grantham, Mayo, Van Otterloo & Co. LLC | 0.04% | 147,354 | $20.9M | ADD+103.4% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 16,467 | $2.3M | REDUCE-87.8% |
| Lee Ainslie Maverick Capital Ltd | 0.00% | 3,856 | $546.9K | NEW |
| Polen Capital Management Polen Capital Management LLC | 0.00% | 1,595 | $226.2K | NEW |